Why the study?
Forecasting demand for the oral poliovirus vaccine stockpile remains challenging despite large global markets, decades of use, and large quantity purchases by national immunization programs and the GPEI.
Answers are grounded in this paper and cite their sources.
Mismatches between supply and demand in the oral polio vaccine stockpile lead to negative consequences including excess costs and potentially preventable cases.
BACKGROUND: Achieving polio eradication requires ensuring the delivery of sufficient supplies of the right vaccines to the right places at the right times. Despite large global markets, decades of use, and large quantity purchases of polio vaccines by national immunization programs and the Global Polio Eradication Initiative (GPEI), forecasting demand for the oral poliovirus vaccine (OPV) stockpile remains challenging. RESEARCH DESIGN AND METHODS: We review OPV stockpile experience compared to pre-2016 expectations, actual demand, and changes in GPEI policies related to the procurement and use of type 2 OPV vaccines. We use available population and immunization schedule data to explore polio vaccine market segmentation, and its role in polio vaccine demand forecasting. RESULTS: We find that substantial challenges remain in forecasting polio vaccine needs, mainly due to (1) deviations in implementation of plans that formed the basis for earlier forecasts, (2) lack of alignment of tactics/objectives among GPEI partners and other key stakeholders, (3) financing, and (4) uncertainty about development and licensure timelines for new polio vaccines and their field performance characteristics. CONCLUSIONS: Mismatches between supply and demand over time have led to negative consequences associated with both oversupply and undersupply, as well as excess costs and potentially preventable cases.
No takes yet. Share an insight, caveat, or question.
Thompson et al. (2023) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: